Newsroom
Sorted by: Latest
-
Securities Fraud Investigation Into Bitdeer Technologies Group (BTDR) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Bitdeer Technologies Group (“Bitdeer” or the “Company”) (NASDAQ: BTDR) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BITDEER (BTDR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On November...
-
Arabic Language Learning Market Trends and Growth Strategies 2025-2032: Learning Modes, Solution Types, End Users, Delivery Platforms, Course Types, Payment Models, Proficiency Levels, Regions - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Arabic Language Learning Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. As global markets become more interconnected, forward-looking organizations are prioritizing Arabic language learning to enhance cross-cultural skills, accelerate international expansion, and future-proof workforce capabilities. Senior decision-makers now recognize that targeted upskilling in Arabic is instrumental for building resilient, adaptiv...
-
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) and reminds investors of the December 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm ha...
-
Bitdeer Technologies Group (BTDR) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Bitdeer Technologies Group (“Bitdeer” or the “Company”) (NASDAQ: BTDR) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BITDEER (BTDR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email...
-
Baby Bath Products (Shampoo, Conditioner, Soap & Shower Gel, Shower Oil, Bath Additives, Other) Market Intelligence 2020-2030 by Price, Distribution Channel and Region - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Baby Bath Products Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global Baby Bath Products Market, valued at USD 5.88 Billion in 2024, is projected to experience a CAGR of 7.01% to reach USD 8.83 Billion by 2030. Market growth is primarily driven by increasing parental awareness regarding infant hygiene and health, coupled with rising disposable incomes in emerging econ...
-
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marex Group
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Marex Group plc (“Marex” or the “Company”) (NASDAQ: MRX) and reminds investors of the December 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has...
-
Number of Shares and Voting Rights of ADOCIA as of December 8th, 2025
LYON, France--(BUSINESS WIRE)--Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French “Code de Commerce” and article 223-16 of the General Regulation of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”), ADOCIA SA, a French société anonyme (corporation), 115, avenue Lacassagne, 69003 Lyon (Euronext Paris: FR0011184241 – ADOC) a clinical-stage biopharmaceutical Company focused on the research and development of innovative therapeutic soluti...
-
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 8 décembre 2025
LYON, France--(BUSINESS WIRE)--Regulatory News: Conformément aux dispositions de l’article L.233-8 II du Code de Commerce et de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers (« AMF »), ADOCIA SA, 115, avenue Lacassagne, 69003 Lyon (Euronext Paris : FR0011184241 – ADOC – la « Société »), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques innovantes pour le traitement du diabète et de l’obésité, pu...
-
Monroe Capital Launches Monroe Capital Enhanced Corporate Lending Fund (MLEND)
CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe Capital”), a leading private credit asset manager, today announced the launch of Monroe Capital Enhanced Corporate Lending Fund (“MLEND” or the “Fund”), a perpetual-life, continuously offered, non-traded business development company designed to provide retail investors access to Monroe’s direct lending strategy. MLEND seeks to deliver consistent current income and attractive risk-adjusted returns that are less correlated with public markets....
-
Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us,” or “our”) today issued the following open letter to the shareholders of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 30.2% of STAAR’s outstanding common stock, continues to oppose the proposed sale of the Company to Alcon Inc. (“Alcon”) (NYSE: ALC) on transaction terms that remain unchanged following the conclusion of the Company’s flawed and...